Dr. Joseph Melancon, head of the kidney-pancreas transplantation unit at Georgetown University Hospital, oversaw the project.

CNN: Massive transplant effort pairs 13 kidneys to 13 patients

But Bristol-Myers hopes to vastly expand this market by testing Erbitux for numerous additional types of cancer, including tumors of the lung, pancreas and head and neck.

FORBES: Bristol, ImClone File On Erbitux